Postauthorisation Safety Study (PASS) of Avatrombopag and Haematological Malignancies in Patients With Primary Immune Thrombocytopaenia

First published 30/09/2024

Last updated 18/12/2024

EU PAS number:

EUPAS1000000315

Study

Planned

Download as PDF

Documents

Study protocol

Initial protocol

5735_ITP PASS Protocol_v1.2_Final_20Dec2023_Redacted.pdf

English (883.6 KB - PDF)View document

Study results

Study report

Other information

Study, other information

SobiITPPASS_DoIs_all.pdf

English (1.3 MB - PDF)View document

ENCePP Seal

ENCePP Seal documents